Hypoglycemia Due to Acquired Carnitine Deficiency in a Pediatric Patient Receiving Chemotherapy

Lauren M. Vasta*, Sarah M. Reynolds, Seppideh Sami, John P. Schacht, Jill E. Emerick, Dina S. Parekh, Karen S. Vogt

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

We describe a 21-month-old male with relapsed clear cell sarcoma of the kidney receiving enteral nutrition who experienced recurrent, ketotic hypoglycemia. During relapse therapy, he had recurrent hypoglycemia episodes, in the setting of hematochezia and diarrhea. Evaluation revealed low carnitine levels. He received supplementation with oral levocarnitine throughout the remainder of treatment, resulting in normalization of serum carnitine levels and no further hypoglycemia. We believe adverse effects of the chemotherapy on his single kidney and gastrointestinal insult resulted in hypoglycemia and carnitine deficiency. Our case highlights that carnitine deficiency should be considered when acute onset hypoglycemia without obvious cause occurs.

Original languageEnglish
Pages (from-to)E496-E499
JournalJournal of Pediatric Hematology/Oncology
Volume44
Issue number2
DOIs
StatePublished - 1 Mar 2022

Keywords

  • cancer
  • carnitine
  • chemotherapy
  • hypoglycemia
  • pediatrics
  • sarcoma

Cite this